The Pharmacist's Role in Cancer Survivorship

As more patients live beyond cancer treatment, survivorship care is becoming an essential—but often overlooked—part of the healthcare journey. This episode explores how pharmacists can support survivors through medication management, mental health awareness, lifestyle counseling, and connection to broader care resources. Tune in to learn how you can play a meaningful role in helping patients navigate life after cancer.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTErica Marchese, PharmD, BCPS, BCOP, BCSCP, MHAClinical Pharmacy Program DirectorCity of HopeJoshua Davis Kinsey and Erica Marchese have no relevant financial relationships to disclose.Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify common physical, emotional, and medication-related challenges faced by patients in the survivorship phase of cancer care.2. Describe the pharmacist's role in supporting survivorship through medication review, lifestyle counseling, and care coordination.0.05 CEU/0.5 HrUAN: 0107-0000-25-292-H01-PInitial release date: 9/15/2025Expiration date: 9/15/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Falls are a leading cause of injury and death in older adults, and pharmacists are in a key position to help prevent them. This episode highlights how to identify medication risks, share practical prevention strategies, and connect patients with trusted tools and resources. Tune in to learn how you can make a meaningful impact in reducing falls in your community. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKristin Meyer PharmD, BCGP, FASCPProfessor of Pharmacy PracticeDrake University College of Pharmacy and Health SciencesJoshua Davis Kinsey and Kristin Meyer have no relevant financial relationships to disclose. RESOURCESNational Council on Aging (NCOA) Falls PreventionNCOA Falls Prevention Awareness WeekNCOA Falls Free CheckUp®CDC STEADIPharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify common medication classes and household hazards associated with increased fall risk in older adults.2. Describe the pharmacist's role in fall prevention through medication review, patient education, and community engagement.0.05 CEU/0.5 HrUAN: 0107-0000-25-269-H05-PInitial release date: 9/8/2025Expiration date: 9/8/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

With shifting policies, payment models, and an unpredictable respiratory virus landscape,  pharmacy teams need more than clinical updates to prepare for the upcoming immunization season. This episode explores key issues shaping immunization practice today — including policy changes, billing and documentation trends, and how teams can proactively adapt and advocate for their role. Tune in for timely insights that go beyond the clinical headlines and complement our in-depth, on-demand course, Annual Immunization Update 2025. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTElizabeth Skoy, PharmDProfessorNorth Dakota State University Joshua Davis Kinsey and Elizabeth Skoy have no relevant financial relationships to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Recognize recent policy and reimbursement updates that influence pharmacy-based immunization services and their potential to improve patient access to care.2. Identify strategies pharmacy teams can use to prepare for the 2025-26 respiratory virus season in ways that support timely, equitable, and effective patient immunization.0.05 CEU/0.5 HrUAN: 0107-0000-25-286-H01-PInitial release date: 9/1/2025Expiration date: 9/1/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Low-dose naltrexone (LDN) is generating growing interest as a potential therapy for conditions such as chronic pain and immune-related disorders. This episode offers a foundational overview of what LDN is, how it’s thought to work, where current evidence stands, and how pharmacists may encounter it in practice. Learn what pharmacists need to know to confidently approach patient questions about LDN and how it fits into current conversations in pharmacy and patient care. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTMichelle Moser, RPhRetired Compounding PharmacistJoshua Davis Kinsey has no relevant financial relationships to disclose.Michelle Moser was a volunteer board member for LDN Research Trust (ended June 2025), a board member for Alliance for Pharmacy Compounding (ended September 2024), and an employee of Revelation Pharma (ended June 2024). All relevant financial relationships have been mitigated.   Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Define low-dose naltrexone (LDN) and describe how it differs from traditional naltrexone dosing.   2. Identify proposed mechanisms of action and areas of emerging interest related to LDN use in practice.0.05 CEU/0.5 HrUAN: 0107-0000-25-275-H01-PInitial release date: 8/25/2025Expiration date: 8/25/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Compounded medications serve a critical role in meeting patient-specific needs, but compliance is essential to ensure safety and quality. This episode covers what pharmacists need to know about documentation, prescription validity, beyond-use dating, and common missteps that can put compliance at risk. Tune in to strengthen your compounding practices and stay aligned with current regulatory expectations. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactJessica Gustin, PharmDCMO & PIC/COOGwinnett Drugs/SynerGrxJoshua Davis Kinsey and Jessica Gustin have no relevant financial relationships to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify key compliance requirements related to patient-specific prescriptions and compounded medication preparation. 2. Describe common compliance challenges in pharmacy compounding and strategies to avoid regulatory missteps. 0.05 CEU/0.5 HrUAN:  0107-0000-25-273-H07-P Initial release date: August 18, 2025Expiration date: August 18, 2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Uncontrolled hypertension continues to drive cardiovascular risk and remains a major gap in chronic disease management. This episode discusses what pharmacists need to know to support treatment adherence, identify therapeutic gaps, and address barriers to blood pressure control. Listen to strengthen your role in helping patients achieve meaningful, sustained outcomes. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTRyan Jacobsen, PharmD, BCPSClinical Pharmacy SpecialistU of Iowa HealthCareJoshua Davis Kinsey and Ryan Jacobsen have no relevant financial relationships to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify common causes and consequences of uncontrolled hypertension in various patient populations.2. Describe the pharmacist's role in recognizing gaps in therapy, addressing adherence, and supporting blood pressure control.0.05 CEU/0.5 HrUAN: 0107-0000-25-271-H01-PInitial release date: 8/11/2025Expiration date: 8/11/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

With sexually transmitted infection (STI) rates continuing to rise, over-the-counter testing kits are expanding access to care, and pharmacists are well-positioned to support their safe and effective use. This episode explores key facts about available OTC kits, regulatory updates, counseling responsibilities, and the potential for test-and-treat models in pharmacy practice. Join us to learn how pharmacists can contribute meaningfully to STI prevention and care. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTElizabeth Skoy, PharmDProfessorNorth Dakota State UniversityJoshua Davis Kinsey and Elizabeth Skoy have no relevant financial relationships to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify the types and regulatory status of over-the-counter STI testing kits available to patients. 2. Describe the pharmacist's role in educating patients on the use of OTC STI kits and recognizing potential opportunities to support follow-up care or treatment.0.05 CEU/0.5 HrUAN: 0107-0000-25-270-H01-PInitial release date: 8/4/2025Expiration date: 8/4/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Pharmacists are key partners in helping patients navigate the challenges of managing pain safely and effectively. This episode covers practical strategies for counseling, identifying potential concerns in therapy, and supporting appropriate treatment, plus a quick review of the newly approved non-opioid option. Tune in to strengthen your clinical confidence and improve outcomes in pain care. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTLorin Fisher PharmD, BCACPResidency Program DirectorUniversity of IowaJoshua Davis Kinsey and Lorin Fisher have no relevant financial relationships to disclose.Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Recognize essential counseling points and patterns in medication use that pharmacists should address when managing patients with pain. 2. Describe the role of pharmacists in supporting safe and effective pain management, including awareness of newly approved medications.0.05 CEU/0.5 HrUAN: 0107-0000-25-258-H08-PInitial release date: 7/28/2025Expiration date: 7/28/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Integrative oncology blends conventional cancer treatments with supportive therapies like nutrition, acupuncture, and mind-body practices to improve patient outcomes and quality of life. This episode outlines what pharmacists need to know about the principles of integrative medicine, how to evaluate evidence-based resources, and counseling tips for guiding patients through safe, effective complementary options. Tune in to strengthen your ability to support cancer patients with credible, compassionate, and comprehensive care. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTGinger Blackmon, PharmD Associate Director of Clinical Initiatives NCODAJoshua Davis Kinsey and Ginger Blackmon have no relevant financial relationships to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Define integrative oncology and identify its role in supporting patients undergoing conventional cancer treatment.2. Describe how pharmacists can evaluate and counsel on evidence-based complementary therapies used in integrative oncology.0.05 CEU/0.5 HrUAN: 0107-0000-25-257-H01-PInitial release date: 7/14/2025Expiration date: 7/14/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Fatty liver disease affects a growing number of patients, often progressing silently until advanced stages. This episode highlights what pharmacists need to know about recent terminology changes, risk factors, pharmacotherapy updates, and key counseling strategies to support patients. Tune in to sharpen your clinical knowledge and help identify, manage, and educate patients at risk for this increasingly common condition.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTSarah Wheeler, PharmD, BCACP, CDCESAssistant ProfessorVCU School of Pharmacy Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current terminology, risk factors, and stages associated with fatty liver disease.2. Identify evidence-based pharmacologic and non-pharmacologic strategies that pharmacists can use to support patients with or at risk for fatty liver disease.0.05 CEU/0.5 HrUAN: 0107-0000-25-219-H01-PInitial release date: 6/23/2025Expiration date: 6/23/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram